查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1504946

寡核苷酸合成市场、占有率、规模、趋势、产业分析报告：依产品、应用、地区、细分市场预测，2024-2032

Oligonucleotide Synthesis Market Share, Size, Trends, Industry Analysis Report, By Product (Synthesized Oligonucleotide Products, Equipment, Reagents, Equipment, and Services); By Application; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球寡核苷酸合成市场规模预计将达到101.7亿美元。本报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

寡核苷酸疗法在治疗视网膜疾病、癌症和心血管疾病等慢性疾病方面显示出巨大潜力。各个生物技术领域寡核苷酸序列的不断发展和新发现预计将推动市场扩张。寡核苷酸合成的一个重要的新兴应用脱颖而出，特别是精准医学中分子诊断的需求显着增加。

用于基因表现分析的高通量定序和 CRISPR（成簇规则间隔短回文重复）等先进方法的整合将简化基因组修饰和遗传筛选，影响对寡核苷酸合成的需求。製造商回应对客製化寡核苷酸不断成长的需求，并积极投资于技术开发，以提高准确性和产量，并促进寡核苷酸更长的生产。

支持寡核苷酸合成市场成长的关键因素是支持基因组进步的监管框架的存在。目的是为先进生物研究及其在人类中的应用创造明确环境的监管政策的预期变化将对寡核苷酸合成的需求产生重大影响。医疗保健领域，特别是干细胞、再生医学、基因工程和合成生物学，被认为是具有巨大潜力的关键领域。国际干细胞研究学会（ISSCR）的道德与公共政策委员会就是一个例子。该委员会由道德、法律和社会政策领域的专家组成，在认识和解决相关问题方面发挥关键作用。

此外，市场受到严格的监管审查，尤其是基因组学的临床应用，在许多国家都受到严格的监督和监管。一些司法管辖区允许基因研究用于非人类应用。监管政策预计将转向为先进生物研究及其人类应用建立明确的框架，这将对寡核苷酸合成的需求产生重大影响。这些变化反映了监管环境的动态格局，影响市场的轨迹，并凸显了不断发展的基因组学领域对合规性和适应性的需求。

寡核苷酸合成市场报告亮点

由于基因组研究的日益普及，预计寡核苷酸合成产品产业将在2023年实现最高成长

在预测期内，PCR 引子区隔预计将主导寡核苷酸合成市场。这是由于基因表现检测和测量的增加。

2023年，由于大公司的存在、技术进步以及对遗传疾病认识的提高，北美地区占据了最大的收入占有率。

由于 ATDBio Ltd.、Bio-Synthesis Inc.、Biosearch Technologies、Eurofins Genomics 和 GE Healthcare 等全球市场参与者的存在，该市场竞争非常激烈。

目录

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 全球寡核苷酸合成市场洞察

  • 行业概况
  • 寡核苷酸合成市场动态
    • 推动因素和机会
      • 日益使用合成寡核苷酸在分子诊断和临床应用中
      • 增加对製药和生技公司的投资
    • 抑制因素和挑战
      • 降低成本
  • PESTLE分析
  • 寡核苷酸合成产业的趋势
  • 价值链分析
  • 新冠肺炎（COVID-19）影响分析

第5章 全球寡核苷酸合成市场：依产品

  • 主要发现
  • 简介
  • 合成寡核苷酸产品
  • 设备
  • 试剂
  • 服务

第6章 全球寡核苷酸合成市场：依应用划分

  • 主要发现
  • 简介
  • PCR 检测与组合
  • PCR 引子
  • DNA 微阵列
  • 定序
  • 反义寡核苷酸
  • 萤光原位杂交（FISH）
  • 其他

第7章 全球寡核苷酸合成市场：依地区

  • 主要发现
  • 简介
    • 寡核苷酸合成市场评估：依地区划分，2019-2032年
  • 北美
    • 北美：依用途，2019-2032年
    • 北美：依产品分类，2019-2032年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依用途，2019-2032年
    • 欧洲：依产品分类，2019-2032年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 亚太地区：依应用程式划分，2019-2032年
    • 亚太地区：依产品分类，2019-2032年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
  • 中东、非洲
    • 中东与非洲：依用途，2019-2032年
    • 中东与非洲：依产品分类，2019-2032年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依用途，2019-2032年
    • 拉丁美洲：依产品分类，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第8章 竞争态势

  • 扩张与收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/揭露

第9章 公司简介

  • Agilent Technologies
  • ATDBio Ltd
  • Bio-Synthesis Inc.
  • Biosearch Technologies
  • Eurofins Genomics
  • GE Healthcare
  • Genewiz
  • GenScript Corporation
  • Integrated DNA Technologies（IDT）
  • LGC Biosearch Technologies
  • Merck KGaA（including Sigma-Aldrich）
  • Nitto Denko Avecia Inc.
  • Thermo Fisher Scientific
  • TriLink BioTechnologies
  • Twist Bioscience
Product Code: PM4917

The global oligonucleotide synthesis market size is expected to reach USD 10.17 billion by 2032, according to a new study by Polaris Market Research. The report "Oligonucleotide Synthesis Market Share, Size, Trends, Industry Analysis Report, By Product (Synthesized Oligonucleotide Products, Equipment, Reagents, Equipment, and Services); By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Oligonucleotide therapeutics exhibit substantial promise in addressing chronic conditions such as retinal disorders, cancers, and cardiovascular, among others. The continuous evolution and newfound implementation of oligo sequences across various biotechnological domains are anticipated to propel market expansion. A significant upsurge in demand for molecular diagnostics, especially in precision care, stands out as a crucial emerging application for oligonucleotide synthesis.

The integration of advanced methodologies such as high-throughput sequencing and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) for gene expression analysis has streamlined genome modification and genetic screening, thereby influencing the demand for oligonucleotide synthesis. Manufacturers are actively investing in technology development to facilitate the production of longer oligonucleotides with enhanced precision and higher yield, aligning with the increasing demand for customized oligos.

The pivotal driver behind oligonucleotide synthesis market growth lies in the presence of a regulatory framework supportive of genomic advancements. Anticipated changes in regulatory policies aimed at creating a well-defined environment for advanced biological research and its application in human use are poised to exert a substantial impact on the demand for oligonucleotide synthesis. Healthcare sectors, particularly in stem cells, regenerative medicine, genetic engineering, and synthetic biology, are identified as key areas with significant potential. An illustrative example is the International Society for Stem Cell Research (ISSCR) ethics and public policy committee, which endeavors to address concerns through transparent discussions. This committee, comprising global experts in ethics, law, and social policy, plays a vital role in recognizing and resolving pertinent issues.

Moreover, the market undergoes rigorous regulatory scrutiny, particularly in the clinical applications of genomics, where stringent monitoring and restrictions prevail in many countries. Some jurisdictions permit genetic research in non-human use sectors. Anticipated shifts in regulatory policies geared towards establishing a well-defined framework for advanced biological research and its application in human use are poised to exert a substantial impact on the demand for oligonucleotide synthesis. These changes reflect the dynamic landscape of regulatory considerations, affecting the market's trajectory and emphasizing the need for compliance and adaptability in the evolving field of genomics.

Oligonucleotide Synthesis Market Report Highlights

In 2023, the synthesized oligonucleotide products segment is expected to witness highest growth during forecast period owing to increased prevalence of genomic studies

PCR primers segment is expected to dominate the oligonucleotide synthesis market during forecast period. This is attributed to increase in detecting and measuring gene expression

In 2023, North America accounted for the largest revenue share due to presence of major players, technological advancements, and growing awareness of genetic disorders.

The market is highly competitive owing to the existence of market players with a global presence, including ATDBio Ltd., Bio-Synthesis Inc., Biosearch Technologies, Eurofins Genomics, GE Healthcare, among others.

Polaris Market Research has segmented the oligonucleotide synthesis market report based on product, application, and region:

Oligonucleotide Synthesis, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Synthesized Oligonucleotide Products
  • Equipment
  • Reagents
  • Services

Oligonucleotide Synthesis, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • PCR Assays and Panels
  • PCR Primers
  • DNA Microarrays
  • Sequencing
  • Antisense Oligonucleotides
  • Fluorescence In Situ Hybridization (FISH)
  • Others

Oligonucleotide Synthesis, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Australia
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LA
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Oligonucleotide Synthesis Market Insights

  • 4.1. Oligonucleotide Synthesis Market - Industry Snapshot
  • 4.2. Oligonucleotide Synthesis Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing utilization of synthesized oligonucleotides in molecular diagnostics and clinical applications
      • 4.2.1.2. Increased investment in pharmaceutical and biotechnology companies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Erosion of costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Oligonucleotide Synthesis Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Oligonucleotide Synthesis Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Oligonucleotide Synthesis, by Product, 2019-2032 (USD Billion)
  • 5.3. Synthesized Oligonucleotide Products
    • 5.3.1. Global Oligonucleotide Synthesis Market, by Synthesized Oligonucleotide Products, by Region, 2019-2032 (USD Billion)
  • 5.4. Equipment
    • 5.4.1. Global Oligonucleotide Synthesis Market, by Equipment, by Region, 2019-2032 (USD Billion)
  • 5.5. Reagents
    • 5.5.1. Global Oligonucleotide Synthesis Market, by Reagents, by Region, 2019-2032 (USD Billion)
  • 5.6. Services
    • 5.6.1. Global Oligonucleotide Synthesis Market, by Services, by Region, 2019-2032 (USD Billion)

6. Global Oligonucleotide Synthesis Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • 6.3. PCR Assays and Panels
    • 6.3.1. Global Oligonucleotide Synthesis Market, by PCR Assays and Panels, by Region, 2019-2032 (USD Billion)
  • 6.4. PCR Primers
    • 6.4.1. Global Oligonucleotide Synthesis Market, by PCR Primers, by Region, 2019-2032 (USD Billion)
  • 6.5. DNA Microarrays
    • 6.5.1. Global Oligonucleotide Synthesis Market, by DNA Microarrays, by Region, 2019-2032 (USD Billion)
  • 6.6. Sequencing
    • 6.6.1. Global Oligonucleotide Synthesis Market, by Sequencing, by Region, 2019-2032 (USD Billion)
  • 6.7. Antisense Oligonucleotides
    • 6.7.1. Global Oligonucleotide Synthesis Market, by Antisense Oligonucleotides, by Region, 2019-2032 (USD Billion)
  • 6.8. Fluorescence In Situ Hybridization (FISH)
    • 6.8.1. Global Oligonucleotide Synthesis Market, by Fluorescence In Situ Hybridization (FISH), by Region, 2019-2032 (USD Billion)
  • 6.9. Others
    • 6.9.1. Global Oligonucleotide Synthesis Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Oligonucleotide Synthesis Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Oligonucleotide Synthesis Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Oligonucleotide Synthesis Market - North America
    • 7.3.1. North America: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
    • 7.3.2. North America: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.3.3. Oligonucleotide Synthesis Market - U.S.
      • 7.3.3.1. U.S.: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.3.4. Oligonucleotide Synthesis Market - Canada
      • 7.3.4.1. Canada: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • 7.4. Oligonucleotide Synthesis Market - Europe
    • 7.4.1. Europe: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.3. Oligonucleotide Synthesis Market - UK
      • 7.4.3.1. UK: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.4. Oligonucleotide Synthesis Market - France
      • 7.4.4.1. France: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.5. Oligonucleotide Synthesis Market - Germany
      • 7.4.5.1. Germany: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.6. Oligonucleotide Synthesis Market - Italy
      • 7.4.6.1. Italy: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.7. Oligonucleotide Synthesis Market - Spain
      • 7.4.7.1. Spain: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.8. Oligonucleotide Synthesis Market - Netherlands
      • 7.4.8.1. Netherlands: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.9. Oligonucleotide Synthesis Market - Russia
      • 7.4.9.1. Russia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • 7.5. Oligonucleotide Synthesis Market - Asia Pacific
    • 7.5.1. Asia Pacific: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.5.3. Oligonucleotide Synthesis Market - China
      • 7.5.3.1. China: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.5.4. Oligonucleotide Synthesis Market - India
      • 7.5.4.1. India: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.5.5. Oligonucleotide Synthesis Market - Malaysia
      • 7.5.5.1. Malaysia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.5.6. Oligonucleotide Synthesis Market - Japan
      • 7.5.6.1. Japan: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.5.7. Oligonucleotide Synthesis Market - Indonesia
      • 7.5.7.1. Indonesia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.5.8. Oligonucleotide Synthesis Market - South Korea
      • 7.5.8.1. South Korea: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • 7.6. Oligonucleotide Synthesis Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.6.3. Oligonucleotide Synthesis Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.6.4. Oligonucleotide Synthesis Market - UAE
      • 7.6.4.1. UAE: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.6.5. Oligonucleotide Synthesis Market - Israel
      • 7.6.5.1. Israel: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.6.6. Oligonucleotide Synthesis Market - South Africa
      • 7.6.6.1. South Africa: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • 7.7. Oligonucleotide Synthesis Market - Latin America
    • 7.7.1. Latin America: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.7.3. Oligonucleotide Synthesis Market - Mexico
      • 7.7.3.1. Mexico: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.7.4. Oligonucleotide Synthesis Market - Brazil
      • 7.7.4.1. Brazil: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.7.5. Oligonucleotide Synthesis Market - Argentina
      • 7.7.5.1. Argentina: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Agilent Technologies
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. ATDBio Ltd
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Bio-Synthesis Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Biosearch Technologies
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Eurofins Genomics
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. GE Healthcare
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Genewiz
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. GenScript Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Integrated DNA Technologies (IDT)
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. LGC Biosearch Technologies
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Merck KGaA (including Sigma-Aldrich)
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Nitto Denko Avecia Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Thermo Fisher Scientific
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. TriLink BioTechnologies
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Twist Bioscience
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development

List of Tables

  • Table 1 Global Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 2 Global Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 3 Oligonucleotide Synthesis Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 5 North America: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 6 U.S.: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 7 U.S.: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 8 Canada: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 9 Canada: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 10 Europe: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Europe: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 12 UK: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 13 UK: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 14 France: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 15 France: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Germany: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 17 Germany: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 18 Italy: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 19 Italy: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 20 Spain: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 21 Spain: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Russia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Russia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 28 China: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 29 China: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 30 India: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 31 India: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 34 Japan: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Japan: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 38 South Korea: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 39 South Korea: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 44 UAE: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 45 UAE: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 46 Israel: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 47 Israel: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 48 South Africa: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 49 South Africa: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 50 Latin America: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 51 Latin America: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Mexico: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Mexico: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Brazil: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Brazil: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 56 Argentina: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 57 Argentina: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Oligonucleotide Synthesis Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Application
  • Figure 7 Global Oligonucleotide Synthesis Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Product
  • Figure 9 Global Oligonucleotide Synthesis Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 10 Oligonucleotide Synthesis Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Oligonucleotide Synthesis Market